EDGAR·FLOW

Dermata Therapeutics, Inc. — Form 8-K

Filed November 17, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 8/100
What the filing says
Dermata Therapeutics filed an 8-K on November 17, 2026 reporting Item 8.01 (Other Events). The filing contains no substantive disclosure of specific business events, counterparties, dollar amounts, dates, or material changes in the form text provided. Only routine SEC filing metadata and XBRL formatting documents are present.
Why this rating

No material event disclosed in accessible text; Item 8.01 is catch-all category. Requires exhibit review to assess substance.

Extracted items
View original filing on SEC.gov ↗ DRMA · stock on Yahoo Finance ↗

See more from November 17, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.